Congress Considers Pay Hike To Retain Top Biomedical Scientists In Government

WASHINGTON—Pressure has been building in Congress to provide higher pay for federal biomedical researchers. But it’s unlikely that any of three bills currently under congressional scrutiny—one of them a well-publicized proposal from President Bush that applies to employees at all government agencies—will make it into law this year. The driving force behind all three of the plans is a desire on the part of federal agencies such as the National Institutes of Health to

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—Pressure has been building in Congress to provide higher pay for federal biomedical researchers. But it’s unlikely that any of three bills currently under congressional scrutiny—one of them a well-publicized proposal from President Bush that applies to employees at all government agencies—will make it into law this year.

The driving force behind all three of the plans is a desire on the part of federal agencies such as the National Institutes of Health to recruit and retain an elite cadre of scientists.

But the proposals face serious opposition from those who don’t want to see scientists’ pay scales treated differently from the pay scales of other federal workers. Those in opposition thus favor maintaining the existing linkage in salary among all government employees.

“This [legislation] breaks that link,” says Michael MilIman, who directed an Institute of Medicine study that evaluated the future of the NIH intramural program. “So it’s a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Elizabeth Pennisi

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours